ConductScience.org, home

Paper41301700

Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential.

Abdelsayed M and 1 other. Biomedicines, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential. Papers, record 41301700. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301700

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.46, provisional
iCite
Revised in PubMed
2025-11-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abdelsayed MMena
2Boulaamane YYassir

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140233673Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: Insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations.Comput Biol Med2025https://conductscience.org/library/papers/40233673PubMed
237655965Structural Basis of PML-RARA Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function.Cancer Discov2023https://conductscience.org/library/papers/37655965PubMed
333054125Differentiation therapy of myeloid leukemia: four decades of development.Haematologica2021https://conductscience.org/library/papers/33054125PubMed
440725243AI-Driven Polypharmacology in Small-Molecule Drug Discovery.Int J Mol Sci2025https://conductscience.org/library/papers/40725243PubMed
536892565Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.Cancer Discov2023https://conductscience.org/library/papers/36892565PubMed
639406957Looking Beyond the Surface: Olutasidenib and Ivosidenib for Treatment of mIDH1 Acute Myeloid Leukemia.Curr Treat Options Oncol2024https://conductscience.org/library/papers/39406957PubMed
737462852Probing the molecular mechanisms of α-synuclein inhibitors unveils promising natural candidates through machine-learning QSAR, pharmacophore modeling, and molecular dynamics simulations.Mol Divers2024https://conductscience.org/library/papers/37462852PubMed
829238707Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Front Med (Lausanne)2017https://conductscience.org/library/papers/29238707PubMed
933034194Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1).J Med Chem2020https://conductscience.org/library/papers/33034194PubMed
1021541964SwissParam: a fast force field generation tool for small organic molecules.J Comput Chem2011https://conductscience.org/library/papers/21541964PubMed
1125558886DataWarrior: an open-source program for chemistry aware data visualization and analysis.J Chem Inf Model2015https://conductscience.org/library/papers/25558886PubMed
1217004707A critical assessment of docking programs and scoring functions.J Med Chem2006https://conductscience.org/library/papers/17004707PubMed
1334265047Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.Blood2021https://conductscience.org/library/papers/34265047PubMed
1428124097Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.Acta Neuropathol2017https://conductscience.org/library/papers/28124097PubMed
1532780180In silico screening of GABA aminotransferase inhibitors from the constituents of Valeriana officinalis by molecular docking and molecular dynamics simulation study.J Mol Model2020https://conductscience.org/library/papers/32780180PubMed
1636976323Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.Mol Cancer Res2023https://conductscience.org/library/papers/36976323PubMed
1732726718Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis.Comput Methods Programs Biomed2020https://conductscience.org/library/papers/32726718PubMed
1825599133Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia.Nat Med2015https://conductscience.org/library/papers/25599133PubMed
1940240608Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation.Nature2025https://conductscience.org/library/papers/40240608PubMed
2016381872The RCSB PDB information portal for structural genomics.Nucleic Acids Res2006https://conductscience.org/library/papers/16381872PubMed

See all 31 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42512057Risk Recognition and Phenotyping in Cardiac and Vascular Diseases.Biomedicines2026https://conductscience.org/library/papers/42512057PubMed
42357359Interpreting the Black Box: Interpretable Machine Learning and Systems Pharmacology in Small-Molecule Therapeutics.Pharmaceutics2026https://conductscience.org/library/papers/42357359PubMed
41976180An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.Molecules2026https://conductscience.org/library/papers/41976180PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
KDM1A23028PubTator's text mininghttps://conductscience.org/library/genes/23028NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301700

GET https://conductscience.org/api/papers/v1/41301700/references?page=2